4//SEC Filing
Richardson Peter C 4
Accession 0001209191-21-040338
CIK 0001016169other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:25 PM ET
Size
7.7 KB
Accession
0001209191-21-040338
Insider Transaction Report
Form 4
Richardson Peter C
EVP, R&D Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-10+69,037→ 69,037 totalExercise: $4.42Exp: 2031-06-10→ Common Stock (69,037 underlying) - Award
Common Stock
2021-06-10$4.42/sh+36,199$160,000→ 36,199 total
Footnotes (3)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F3]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001343502
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:25 PM ET
- Size
- 7.7 KB